Approval · Notice of Compliance 5221 · 1995
PROMETRIUM: Notice of Compliance 5221
Issued May 15, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5221
- Date
- May 15, 1995
- Company
- Schering Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Progestin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROMETRIUM | 02166704 | Marketed |
Medicinal ingredients
- PROGESTERONE 100 MG per CAP